Remus Pharmaceuticals Limited

Remus Pharmaceuticals Limited is a publicly traded company in India (NSE: REMUS), Manufacturing Sites in the USA and India, with capabilities to make oral solids and Injectables, with special focus on Critical Care, Oncology, Nephrology, CNS, Cardiology and Diabetic categories of Products. Front end marketing and distribution in Latin America and other emerging global markets like the Philippines, Myanmar, CIS and African markets. It specializes in, first to market, soon to go off patent, specialty and complex products, with utmost focus on quality with affordability.